HEALTH CATALYST, INC. (HCAT) News
Filter HCAT News Items
HCAT News Results
|Loading, please wait...|
HCAT News Highlights
- For HCAT, its 30 day story count is now at 5.
- Over the past 22 days, the trend for HCAT's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about HCAT are MSFT, NXGN and ORCL.
Latest HCAT News From Around the Web
Below are the latest news stories about HEALTH CATALYST INC that investors may wish to consider to help them evaluate HCAT as an investment opportunity.
In this article, we will take a look at the 14 small-cap stocks with high potential. You can skip this part and go to 5 Small-Cap Stocks with High Potential. Small-cap investors took a beating in 2022 as data shows that small-cap stocks are near their all-time lows. According to data from Royce Investment Partners, […]
Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that the leadership of the Church of Jesus Christ of Latter-Day Saints has called Paul Horstmeier, Health Catalyst's Chief Operating Officer, to serve for three years as the Mission President of the Puerto Rico San Juan Mission, beginning in late June 2023.
Tech stocks had as difficult a year as any sector in 2022, with the Nasdaq-100 tech index falling more than 39% over the past year. It's hard to find tech stocks, which are known for their growth, that weren't hit by falling share prices. Health Catalyst (NASDAQ: HCAT), Oracle (NYSE: ORCL), and Microsoft (NASDAQ: MSFT) are all poised to bounce back this year because their financials never really faltered, despite negative market sentiment for the sector.
In this article we are going to estimate the intrinsic value of Health Catalyst, Inc. ( NASDAQ:HCAT ) by projecting its...
SALT LAKE CITY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the 41st Annual J.P. Morgan Healthcare Conference, being held in San Francisco, including a presentation on Tuesda
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expansive, multi-year contract with Carle Health (Carle)—an integrated health system based in Urbana, Illinois that includes five hospitals, multi-specialty physician group practices with more than 1,000 doctors and advanced practice providers, and Health Alliance Medical Plans—deepening its relationship with Health Catalyst to
The consensus price target hints at a 61.5% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ClearBridge Investments, an investment management company, published its “ClearBridge Small Cap Growth Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy underperformed its benchmark, the Russell 2000 Growth Index, declining about 1%. Overall stock selection and sector allocation drove the strategy to underperform in […]
Those following along with Health Catalyst, Inc. ( NASDAQ:HCAT ) will no doubt be intrigued by the recent purchase of...